Kazuyoshi Kanno

Kazuyoshi Kanno

Auto-generated profile, based on publicly available information

Kazuyoshi Kanno

Department of Cardiovascular Surgery, Mt. Fuji Shizuoka Children's Hospital, Shizuoka, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
KSKisaburo Sakamoto
Kisaburo Sakamoto
NONoritaka Ota
Noritaka Ota
YFYoshifumi Fujimoto
Yoshifumi Fujimoto
MMMasaya Murata
Masaya Murata
YIYujiro Ide
Yujiro Ide
TFTomoyuki Fujita
Tomoyuki Fujita

27 May 2019 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
MSMikio Sugano
Mikio Sugano
MMMasaya Murata
Masaya Murata
YIYujiro Ide
Yujiro Ide
HIHiroki Ito
Hiroki Ito
KKKazuyoshi Kanno
Kazuyoshi Kanno
KSKisaburou Sakamoto
Kisaburou Sakamoto

13 March 2017 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
KIKenta Imai
Kenta Imai
MMMasaya Murata
Masaya Murata
YIYujiro Ide
Yujiro Ide
MSMikio Sugano
Mikio Sugano
HIHiroki Ito
Hiroki Ito
KSKisaburo Sakamoto
Kisaburo Sakamoto
Patients who underwent CAVV plasty with or after BCPS had good outcomes; the outcome of patients with CAVV plasty was the same as that of those without CAVV plasty. Treatment for patients who require CAVV plasty before BCPS, especially neonates, is challenging.

13 March 2015 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
MTMaiko Tachi
Maiko Tachi
MMMasaya Murata
Masaya Murata
YIYujiro Ide
Yujiro Ide
HIHiroki Ito
Hiroki Ito
KKKazuyoshi Kanno
Kazuyoshi Kanno
KSKisaburo Sakamoto
Kisaburo Sakamoto
The bilaterally unbalanced development of pulmonary arteries (PAs), as a result of unilateral pulmonary arterial hypoplasia (PAhypo) makes patients either ineligible for the Fontan operation or candidates for the one-lung Fontan operation. In the present study, we examined the efficacy of intrapulmonary-artery septation (IPAS), a technique we reported in 2007 in which a septation is constructed within the central PA, in patients with unilateral PAhypo. Sixteen patients with unilateral PAhypo and an affected PA index of ≤60 mm 2 /m 2 , including non-confluent PA (NCPA), underwent IPAS between January 2000 and March 2012; patients with pulmonary venous obstruction were excluded from this study. We compared the affected PA index values before and after IPAS and after the Fontan operation as well as the bilateral pulmonary blood flow ratio using pulmonary scintigraphy. The post-Fontan operation values of central venous pressure (CVP), pulmonary vascular resistance (PVR), ventricular end-diastolic pressure (VEDP), cardiac index (CI) and arterial oxygen saturation (SaO 2 ) at the most recent cardiac catheterization, as well as the pre-IPAS and post-Fontan New York Heart Association (NYHA) classification levels were examined. One patient died after IPAS (survival rate, 93.8%). Thirteen (86.7%) of the surviving 15 patients underwent the Fontan operation. The mean PA indexes were 25.5 ± 18.9 mm 2 /m 2 before IPAS and 67.9 ± 34.2 mm 2 /m 2 after IPAS ( P = 0.003); the mean PA index was 71.1 ± 50.0 mm 2 /m 2 after the Fontan operation. Restenosis did not occur after the Fontan operation, and the PA diameters were maintained. The mean affected/unaffected lung blood flow ratio was 0.89 ± 0.67. The most recent cardiac catheterization after the Fontan operation indicated the following values: CVP, 11.7 ± 1.8 mmHg; PVR, 1.3 ± 0.4 U m 2 ; EDP, 5.7 ± 2.0 mmHg; CI, 3.1 ± 0.5 l/min/m 2 and SaO 2 , 94.9 ± 2.0%. The mean pre-IPAS and post-Fontan NYHA levels were 2.3 ± 0.6 and 1.2 ± 0.4, respectively ( P = 0.0002). With IPAS, the affected PA diameters increased significantly, and were maintained after the Fontan operation, and continuity of the native PAs was achieved. IPAS is very effective for patients suffering from otherwise intractable diseases.

19 July 2019 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
KKKazuyoshi Kanno
Kazuyoshi Kanno
AIAkio Ikai
Akio Ikai
MMMasaya Murata
Masaya Murata
KSKisaburo Sakamoto
Kisaburo Sakamoto

13 February 2020 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
MIMotonori Ishidou
Motonori Ishidou
KOKeisuke Ota
Keisuke Ota
KWKentaro Watanebe
Kentaro Watanebe
HKHiroshi Koshiyama
Hiroshi Koshiyama
KKKazuyoshi Kanno
Kazuyoshi Kanno
KSKisaburo Sakamoto
Kisaburo Sakamoto
OBJECTIVES: Patients with unbalanced pulmonary artery (PA) growth and decreased unilateral pulmonary circulation are considered unsuitable candidates for the Fontan procedure. Following our previous study on the utility of intrapulmonary-artery septation for patients with PA hypoplasia, we investigated its use in patients with pulmonary venous obstruction (PVO). METHODS: We recruited 42 patients who underwent intrapulmonary-artery septation for unilateral PA hypoplasia and/or PVO between 1998 and 2018 and classified them into no PVO or PVO group. We analysed overall survival, success of the Fontan procedure and data from catheterization and echocardiography. In PVO, we evaluated the functional lung area before the Fontan procedure and the relevance of this parameter to operative outcomes. RESULTS: The PVO and no-PVO group included 24 and 18 patients, respectively. One patient in the no-PVO and 6 patients in the PVO group died during follow-up; this difference was statistically significant (log-rank P = 0.040). In the no-PVO group, 15 (83%) patients achieved two-lung Fontan circulation. In the PVO group, 12 (50%) patients achieved two-lung Fontan circulation. Multivariate analysis revealed that functional lung area and shunt size [significantly larger in patients with functional lung area ≥50% in affected lung (P = 0.040)] were significant factors for successful two-lung Fontan procedure (P = 0.030). CONCLUSIONS: Intrapulmonary-artery septation may contribute to increase functional lung area after PVO release to establish two-lung Fontan circulation in patients with PVO who have unbalanced PA growth and/or decreased unilateral pulmonary circulation.